RU486 administration improves glycemic control and insulin sensitivity in rodents given HFD for 4 weeks [27] and lowers glycated hemoglobin levels in patients with Cushing's syndrome who often exhibit poor glycemic control [24]. This evidence concerns the gene INS and Cushing syndrome.